InvestorsHub Logo
Followers 58
Posts 10142
Boards Moderated 1
Alias Born 09/21/2016

Re: Talon38 post# 140298

Thursday, 02/08/2018 4:40:37 AM

Thursday, February 08, 2018 4:40:37 AM

Post# of 462130

Thanks to Dr. Percy for his discussion of a possible late 2018 or early 2019 launch. We reached out to Neuren for a timeline update and want to share their response.
“Neuren has not yet confirmed the timeline, but there is a huge amount of preparation underway by Neuren and others to get ready for the trial, which is larger, longer and more complex than the previous two studies. Things are moving along nicely, but many different aspects have to be perfect before the trial starts, including approval of the protocol, manufacturing, trial sites, and logistics. All of these aspects are being worked on. Neuren will provide further updates in due course.” Jon Pilcher, CFO & Company Secretary, Neuren Pharmaceuticals



We should all be looking forward to the day when it is understood that large population in trials is NOT A SIGN OF GOODNESS, in fact it is the opposite, IMO. These people rely on stabbing around in the dark. SAD.

According to new trials protocols in precision medicine once the lab work has been done the outcome is certain, within some confidence envelope. When the science is solid, understood and reproducible there will be no guesswork. Any need big trial is really a sign of weakness in the science or our understanding of it. That day is coming soon. We will recognize it when we see it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News